Security key
01626L204
Aligos Therapeutics, Inc. - Common Stock, par value, $0.0001 per share (ALGS)
CUSIP: 01626L204
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value, $0.0001 per share
- Total 13F shares
- 1,619,199
- Total 13F value
- $64,508,583
- Share change
- -75,665
- SEC-reported price per share
- $39.84
- Number of holders
- 33
- Value change
- +$11,813,062
- Number of buys
- 20
- Number of sells
- 9
- Shares outstanding
- 5,646,929
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
33
Top holders
10
ALGS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Aligos Therapeutics, Inc. SEC filings
Aligos Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 01626L204
Recent filing periods:
Ownership snapshot
Top reported holders of ALGS - Aligos Therapeutics, Inc. - Common Stock, par value, $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
13D/G
Lead comparable stake: 5%
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
5%
EcoR1 Capital, LLC
4.5%
Deep Track Capital, LP
4.3%
ADAGE CAPITAL PARTNERS GP, L.L.C.
3.9%
Vivo Capital, LLC
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
13D/G
Company
|
5%
from 13D/G
|
$2,728,723
315,095 shares
|
— | 30 Sep 2024 |
| EcoR1 Capital, LLC |
13F
Company
|
4.5%
|
$2,213,262
255,573 shares
|
— | 30 Sep 2024 |
| Deep Track Capital, LP |
13F
Company
|
4.3%
|
$2,113,993
244,110 shares
|
— | 30 Sep 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
3.9%
|
$1,894,921
218,813 shares
|
— | 30 Sep 2024 |
| Vivo Capital, LLC |
13F
Company
|
2.5%
|
$1,228,672
141,879 shares
|
— | 30 Sep 2024 |
| Woodline Partners LP |
13F
Company
|
1.6%
|
$796,469
91,971 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
1,619,199
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q1 2026 Across Filers
Q1 2026 holders
34
Q4 2024 holders
33
Holder diff
-1
| Investor | Q1 2026 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend